TPWA
SLS icon

Twin Peaks Wealth Advisors’s SELLAS Life Sciences SLS Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-40
Closed -$169 – 1876
2026
Q1 		$169 Buy
+40
New +$179 ﹤0.01% 2196

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Twin Peaks Wealth Advisors's SLS Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of SELLAS Life Sciences (SLS) in Q2 2026, closing a stake of 40 shares — an estimated $169 sold.

Twin Peaks Wealth Advisors first reported a position in SLS in Q1 2026 and held it in 1 quarter. The position peaked at $169 in Q1 2026. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Twin Peaks Wealth Advisors reported no remaining SELLAS Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 40 SELLAS Life Sciences shares in Q2 2026, an estimated $169.
  • Twin Peaks Wealth Advisors first reported a position in SELLAS Life Sciences in Q1 2026 and held it in 1 quarter.
  • Twin Peaks Wealth Advisors's SELLAS Life Sciences position peaked at $169 in Q1 2026.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.